Diet, exercise, and glucose-lowering medication are first-line treatments for type 2 diabetes, but morbidity and mortality remain high because many patients do not adequately adhere to these treatments. Treatment adherence provides its greatest health benefits (e.g., avoidance of diabetes-related complications such as renal disease) only after months or years of sustained lifestyle change; however, accumulating evidence demonstrates that individuals suffering from type 2 diabetes and related disorders (e.g., obesity) rapidly devalue the future and show a bias for immediate gratification. The overall goal of this project is to improve treatment adherence in type 2 diabetes using an episodic future thinking intervention (i.e., mental prospection) designed to increase valuation of the future.

Jeffrey Scott Stein, PhD

Principal Investigator

jstein1@vtc.vt.edu

Virginia Tech Carilion Research Institute

Center for Transformative Research on Health Behaviors

Roanoke, VA

Jeff Stein is a research assistant professor in the VTCRI Center for Transformative Research on Health Behaviors. His research interests include behavioral economics, neuroeconomics, addiction, obesity, and health behavior.

Martha Matocha, PhD

NIH/NINR

Program Official

martha.matocha@nih.gov